- Home
- ACRV vs NKSH Comparison
ACRV vs NKSH Comparison
Compare ACRV & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- NKSH
- Stock Information
- Founded
- ACRV 2018
- NKSH 1891
- Country
- ACRV United States
- NKSH United States
- Employees
- ACRV N/A
- NKSH N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- NKSH Major Banks
- Sector
- ACRV Health Care
- NKSH Finance
- Exchange
- ACRV Nasdaq
- NKSH Nasdaq
- Market Cap
- ACRV 189.0M
- NKSH 190.8M
- IPO Year
- ACRV 2022
- NKSH N/A
- Fundamental
- Price
- ACRV $5.54
- NKSH $27.51
- Analyst Decision
- ACRV Strong Buy
- NKSH Strong Buy
- Analyst Count
- ACRV 6
- NKSH 1
- Target Price
- ACRV $22.40
- NKSH $38.00
- AVG Volume (30 Days)
- ACRV 69.3K
- NKSH 7.8K
- Earning Date
- ACRV 03-27-2025
- NKSH 01-23-2025
- Dividend Yield
- ACRV N/A
- NKSH 5.49%
- EPS Growth
- ACRV N/A
- NKSH N/A
- EPS
- ACRV N/A
- NKSH 1.24
- Revenue
- ACRV N/A
- NKSH $44,130,000.00
- Revenue This Year
- ACRV N/A
- NKSH N/A
- Revenue Next Year
- ACRV N/A
- NKSH $9.78
- P/E Ratio
- ACRV N/A
- NKSH $22.24
- Revenue Growth
- ACRV N/A
- NKSH N/A
- 52 Week Low
- ACRV $3.83
- NKSH $26.00
- 52 Week High
- ACRV $11.90
- NKSH $35.00
- Technical
- Relative Strength Index (RSI)
- ACRV 47.59
- NKSH 38.28
- Support Level
- ACRV $5.00
- NKSH $28.51
- Resistance Level
- ACRV $6.08
- NKSH $28.88
- Average True Range (ATR)
- ACRV 0.64
- NKSH 0.63
- MACD
- ACRV 0.01
- NKSH -0.11
- Stochastic Oscillator
- ACRV 25.68
- NKSH 0.00
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.